---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-042811"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2022-04-05T23:59:59+00:00"
generated_at: "2026-06-26T09:31:23.941405+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tivic Health appoints Veronica Cai as CFO, Ryan Sabia as COO; CFO Benz resigns

## Summary
- Briana Benz resigned as CFO effective April 1, 2022; 93,750 restricted shares repurchased for $375.
- Veronica Cai appointed CFO with $325k base salary, 25% bonus target, and options for 117,880 shares at $1.61.
- Ryan Sabia (COO since Dec 2021) enters employment agreement with $250k base salary and 25% bonus target.
- Sanjay Ahuja joins as SVP Quality Assurance & Regulatory Affairs (press release).
- Benz's departure not due to any disagreement with the company's operations or policies.

## SEC filing metadata
- accession: 0001104659-22-042811
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2022-04-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.02, 1.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000110465922042811/0001104659-22-042811-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000110465922042811/tm2211661d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-042811
- JSON: https://secwatch.observer/filing/0001104659-22-042811.json
- Plain text: https://secwatch.observer/filing/0001104659-22-042811.txt

## Key facts
- Executive change
  Veronica Cai was appointed as Chief Financial Officer at Valion Bio, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On April 1, 2022, Veronica Cai was appointed as the Company’s new Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787740/000110465922042811/0001104659-22-042811-index.htm
- Executive change
  Briana Benz resigned as Chief Financial Officer at Valion Bio, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On April 1, 2022, Briana Benz resigned from her role as Chief Financial Officer of Tivic Health Systems, Inc., a Delaware corporation (the “Company”), to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787740/000110465922042811/0001104659-22-042811-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.